| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |